Potential predictors of depressive relapse following repetitive Transcranial Magnetic Stimulation: A systematic review

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Background: Repetitive Transcranial Magnetic Stimulation (rTMS) is widely approved treatment for major depressive disorder (MDD). However, around 50% of individuals who recover from depression following rTMS interventions experience a relapse of depressive symptomatology by 12 months. The short-term durability of the rTMS treatment effect has been systematically investigated. However, variables relating to the long-term durability of the antidepressant effect produced by rTMS are less understood. Therefore, the current review systematically assessed the research on variables relating to relapse following rTMS. Method: This systematic review was performed according to PRISMA guidelines. A comprehensive electronic literature search for terms related to relapse following rTMS treatment for MDD was performed on studies published before the end of October 2018. Results: A total of 18 studies assessing relapse related variables were identified. While there is some indication that comorbid anxiety, acute response, and residual symptomatology may hold predictive potential for depressive relapse following rTMS treatment, findings were not sufficient to draw reliable conclusions. Discussion: Identified studies assessed three main categories of variables including demographic information, clinical characteristics and rating scale scores, and rTMS treatment specific factors. Only a small number of studies were available, and considerable inconsistency exists between studies, only limited conclusions were able to be drawn. Conclusion: More studies assessing a wider range of predictor variables such as cognitive or neuroimaging markers are needed.

Original languageEnglish
Pages (from-to)317-323
Number of pages7
JournalJournal of Affective Disorders
Volume256
DOIs
Publication statusPublished - 1 Sep 2019

Keywords

  • Durability
  • Major depressive disorder
  • Predict
  • Relapse
  • Repetitive Transcranial Magnetic Stimulation
  • Risk

Cite this

@article{92b10372d1344ab49918cb9d641605a6,
title = "Potential predictors of depressive relapse following repetitive Transcranial Magnetic Stimulation: A systematic review",
abstract = "Background: Repetitive Transcranial Magnetic Stimulation (rTMS) is widely approved treatment for major depressive disorder (MDD). However, around 50{\%} of individuals who recover from depression following rTMS interventions experience a relapse of depressive symptomatology by 12 months. The short-term durability of the rTMS treatment effect has been systematically investigated. However, variables relating to the long-term durability of the antidepressant effect produced by rTMS are less understood. Therefore, the current review systematically assessed the research on variables relating to relapse following rTMS. Method: This systematic review was performed according to PRISMA guidelines. A comprehensive electronic literature search for terms related to relapse following rTMS treatment for MDD was performed on studies published before the end of October 2018. Results: A total of 18 studies assessing relapse related variables were identified. While there is some indication that comorbid anxiety, acute response, and residual symptomatology may hold predictive potential for depressive relapse following rTMS treatment, findings were not sufficient to draw reliable conclusions. Discussion: Identified studies assessed three main categories of variables including demographic information, clinical characteristics and rating scale scores, and rTMS treatment specific factors. Only a small number of studies were available, and considerable inconsistency exists between studies, only limited conclusions were able to be drawn. Conclusion: More studies assessing a wider range of predictor variables such as cognitive or neuroimaging markers are needed.",
keywords = "Durability, Major depressive disorder, Predict, Relapse, Repetitive Transcranial Magnetic Stimulation, Risk",
author = "Aleksandra Miljevic and Bailey, {Neil W.} and Herring, {Sally E.} and Fitzgerald, {Paul B.}",
year = "2019",
month = "9",
day = "1",
doi = "10.1016/j.jad.2019.06.006",
language = "English",
volume = "256",
pages = "317--323",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

Potential predictors of depressive relapse following repetitive Transcranial Magnetic Stimulation : A systematic review. / Miljevic, Aleksandra; Bailey, Neil W.; Herring, Sally E.; Fitzgerald, Paul B.

In: Journal of Affective Disorders, Vol. 256, 01.09.2019, p. 317-323.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Potential predictors of depressive relapse following repetitive Transcranial Magnetic Stimulation

T2 - A systematic review

AU - Miljevic, Aleksandra

AU - Bailey, Neil W.

AU - Herring, Sally E.

AU - Fitzgerald, Paul B.

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Background: Repetitive Transcranial Magnetic Stimulation (rTMS) is widely approved treatment for major depressive disorder (MDD). However, around 50% of individuals who recover from depression following rTMS interventions experience a relapse of depressive symptomatology by 12 months. The short-term durability of the rTMS treatment effect has been systematically investigated. However, variables relating to the long-term durability of the antidepressant effect produced by rTMS are less understood. Therefore, the current review systematically assessed the research on variables relating to relapse following rTMS. Method: This systematic review was performed according to PRISMA guidelines. A comprehensive electronic literature search for terms related to relapse following rTMS treatment for MDD was performed on studies published before the end of October 2018. Results: A total of 18 studies assessing relapse related variables were identified. While there is some indication that comorbid anxiety, acute response, and residual symptomatology may hold predictive potential for depressive relapse following rTMS treatment, findings were not sufficient to draw reliable conclusions. Discussion: Identified studies assessed three main categories of variables including demographic information, clinical characteristics and rating scale scores, and rTMS treatment specific factors. Only a small number of studies were available, and considerable inconsistency exists between studies, only limited conclusions were able to be drawn. Conclusion: More studies assessing a wider range of predictor variables such as cognitive or neuroimaging markers are needed.

AB - Background: Repetitive Transcranial Magnetic Stimulation (rTMS) is widely approved treatment for major depressive disorder (MDD). However, around 50% of individuals who recover from depression following rTMS interventions experience a relapse of depressive symptomatology by 12 months. The short-term durability of the rTMS treatment effect has been systematically investigated. However, variables relating to the long-term durability of the antidepressant effect produced by rTMS are less understood. Therefore, the current review systematically assessed the research on variables relating to relapse following rTMS. Method: This systematic review was performed according to PRISMA guidelines. A comprehensive electronic literature search for terms related to relapse following rTMS treatment for MDD was performed on studies published before the end of October 2018. Results: A total of 18 studies assessing relapse related variables were identified. While there is some indication that comorbid anxiety, acute response, and residual symptomatology may hold predictive potential for depressive relapse following rTMS treatment, findings were not sufficient to draw reliable conclusions. Discussion: Identified studies assessed three main categories of variables including demographic information, clinical characteristics and rating scale scores, and rTMS treatment specific factors. Only a small number of studies were available, and considerable inconsistency exists between studies, only limited conclusions were able to be drawn. Conclusion: More studies assessing a wider range of predictor variables such as cognitive or neuroimaging markers are needed.

KW - Durability

KW - Major depressive disorder

KW - Predict

KW - Relapse

KW - Repetitive Transcranial Magnetic Stimulation

KW - Risk

UR - http://www.scopus.com/inward/record.url?scp=85067314575&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2019.06.006

DO - 10.1016/j.jad.2019.06.006

M3 - Review Article

VL - 256

SP - 317

EP - 323

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -